To further investigate pharmacological TIAM1/RAC1 signaling inhibition in the context of human BPH, we exposed BPH PDOs with varying concentrations of NSC23766 and assessed growth effects compared with vehicle controls. The gene discussed is RAC1; the disease is benign prostatic hyperplasia.